comparemela.com

Page 23 - Rd Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

4Bio Capital: 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing

Press Release 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing 7 June 2022 London & Greater Philadelphia - 4BIO Capital

Code Bio corrals $75M to skip viruses, use synthetic DNA for genetic meds delivery

Code Biotherapeutics uses synthetic DNA as the foundation for its genetic medicines, which the startup claims offer several key advantages compared to genetic medicines delivered via engineered viruses. The startup plans to use its new capital to develop lead programs in Duchenne muscular dystrophy and type 1 diabetes.

Code Bio Raises $75 Million to Develop Therapies for Debilitating Genetic Diseases

Code Bio Raises $75 Million to Develop Therapies for Debilitating Genetic Diseases
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.